Cross-talk between NKT and regulatory T cells (Tregs) in modulation of immune response in patients with colorectal cancer following different pain management techniques
- PMID: 22220404
Cross-talk between NKT and regulatory T cells (Tregs) in modulation of immune response in patients with colorectal cancer following different pain management techniques
Abstract
Natural killer T (NKT) and regulatory T cells (Tregs) play an important role in innate immune response. Natural killer (NK) and NKT cells are indispensable factors in the body's ongoing defense against tumor development, as well as viral infection. NKT cells are a subset of T cells that shares properties of natural killer cells and conventional T cells. They are involved in innate immune responses, tumor rejection, post transplantation immunotherapy, immune surveillance and control of autoimmune diseases. They may also play both protective and harmful roles in the progression of certain autoimmune diseases, such as diabetes, lupus, atherosclerosis, and allergen-induced asthma. Immune surveillance involves the process whereby precancerous and malignant cells are recognized by the host immune system as damaged and are consequently targeted for elimination. The pharmacological management of postoperative pain in patients with malignancies uses very different techniques whose possible cytotoxic functions we still known very poor. The present study compared effects of two different postoperative pain management techniques in patients undergoing colorectal cancer surgery on the innate immunity. Our data indicate that the patients with colorectal cancer have significantly increased the percentage of Tregs and NKT cells. The values were statistically higher during epidural analgesia in comparison with intravenous analgesia, indicating that epidural pain management technique ameliorate the immune suppression after surgery.
Similar articles
-
The proposed mechanism of action during different pain management techniques on expression of cytolytic molecule perforin in patients after colorectal cancer surgery.Med Hypotheses. 2011 Mar;76(3):450-2. doi: 10.1016/j.mehy.2010.11.019. Epub 2010 Dec 30. Med Hypotheses. 2011. PMID: 21195559
-
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.Immunol Rev. 2006 Dec;214:229-38. doi: 10.1111/j.1600-065X.2006.00445.x. Immunol Rev. 2006. PMID: 17100888 Review.
-
The regulatory effect of natural killer cells: do "NK-reg cells" exist?Cell Mol Immunol. 2006 Aug;3(4):241-54. Cell Mol Immunol. 2006. PMID: 16978532 Review.
-
CD4+CD25+ Tregs and NKT cells: regulators regulating regulators.Trends Immunol. 2006 Jul;27(7):322-7. doi: 10.1016/j.it.2006.05.003. Epub 2006 Jun 2. Trends Immunol. 2006. PMID: 16735139 Review.
-
Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs.Int Immunol. 2005 Sep;17(9):1143-55. doi: 10.1093/intimm/dxh292. Epub 2005 Jul 18. Int Immunol. 2005. PMID: 16027139
Cited by
-
The Effect of Anesthesia on the Immune System in Colorectal Cancer Patients.Can J Gastroenterol Hepatol. 2018 Apr 1;2018:7940603. doi: 10.1155/2018/7940603. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 29805965 Free PMC article. Review.
-
Interventional factors influencing natural killer cell immunity in colorectal cancer: a systematic review.Cancer Immunol Immunother. 2025 Feb 1;74(3):91. doi: 10.1007/s00262-024-03900-5. Cancer Immunol Immunother. 2025. PMID: 39891716 Free PMC article.
-
Immune cell subset differentiation and tissue inflammation.J Hematol Oncol. 2018 Jul 31;11(1):97. doi: 10.1186/s13045-018-0637-x. J Hematol Oncol. 2018. PMID: 30064449 Free PMC article. Review.